S&P 500

5.477,90

0,16%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Profound Medical Corporation (PROF)
Profound Medical Corporation (PROF) Notícias

PROF

Profound Medical (PROF)

Profound Medical Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PROF

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/06/2024	18:23	Edgar (US Regulatory)	Form F-X - Appointment of Agent for Service of Process and Undertaking	NASDAQ:PROF	Profound Medical Corporation
14/06/2024	18:01	Edgar (US Regulatory)	Form F-10 - Registration Statement for Securities of certain Canadian Issuers.	NASDAQ:PROF	Profound Medical Corporation
14/06/2024	17:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PROF	Profound Medical Corporation
15/05/2024	18:00	GlobeNewswire Inc.	Profound Medical Annual General Meeting of Shareholders Voting Results	NASDAQ:PROF	Profound Medical Corporation
15/05/2024	17:12	PR Newswire (Canada)	PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS	NASDAQ:PROF	Profound Medical Corporation
14/05/2024	08:30	GlobeNewswire Inc.	Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan	NASDAQ:PROF	Profound Medical Corporation
09/05/2024	17:05	GlobeNewswire Inc.	Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance	NASDAQ:PROF	Profound Medical Corporation
06/05/2024	17:15	GlobeNewswire Inc.	Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum	NASDAQ:PROF	Profound Medical Corporation
22/04/2024	17:15	GlobeNewswire Inc.	Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
09/04/2024	08:45	GlobeNewswire Inc.	Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:PROF	Profound Medical Corporation
07/03/2024	18:05	GlobeNewswire Inc.	Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PROF	Profound Medical Corporation
04/03/2024	18:30	GlobeNewswire Inc.	Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference	NASDAQ:PROF	Profound Medical Corporation
27/02/2024	09:45	GlobeNewswire Inc.	Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	NASDAQ:PROF	Profound Medical Corporation
15/02/2024	18:30	GlobeNewswire Inc.	Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
16/01/2024	18:30	GlobeNewswire Inc.	Profound Medical Announces Non-Brokered Private Placement	NASDAQ:PROF	Profound Medical Corporation
03/01/2024	18:15	GlobeNewswire Inc.	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues	NASDAQ:PROF	Profound Medical Corporation
28/12/2023	00:40	GlobeNewswire Inc.	Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares	NASDAQ:PROF	Profound Medical Corporation
27/12/2023	18:15	GlobeNewswire Inc.	Profound Medical Announces Proposed Public Offering of Common Shares	NASDAQ:PROF	Profound Medical Corporation
08/11/2023	09:45	GlobeNewswire Inc.	Profound Medical to Participate in the Stifel 2023 Healthcare Conference	NASDAQ:PROF	Profound Medical Corporation
03/11/2023	09:00	GlobeNewswire Inc.	Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting	NASDAQ:PROF	Profound Medical Corporation
02/11/2023	17:05	GlobeNewswire Inc.	Profound Medical Announces Third Quarter 2023 Financial Results	NASDAQ:PROF	Profound Medical Corporation
19/10/2023	17:30	GlobeNewswire Inc.	Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
10/10/2023	17:30	GlobeNewswire Inc.	Profound Medical 2023 Virtual Analyst & Investor Day Agenda	NASDAQ:PROF	Profound Medical Corporation
25/09/2023	17:05	GlobeNewswire Inc.	Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost	NASDAQ:PROF	Profound Medical Corporation
21/09/2023	09:00	GlobeNewswire Inc.	Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13	NASDAQ:PROF	Profound Medical Corporation
19/09/2023	17:45	GlobeNewswire Inc.	Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference	NASDAQ:PROF	Profound Medical Corporation
06/09/2023	20:23	GlobeNewswire Inc.	Profound Medical Announces At-the-Market Offering of up to US$30,000,000	NASDAQ:PROF	Profound Medical Corporation
09/08/2023	17:05	GlobeNewswire Inc.	Profound Medical Announces Second Quarter 2023 Financial Results	NASDAQ:PROF	Profound Medical Corporation
02/08/2023	17:30	GlobeNewswire Inc.	Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow	NASDAQ:PROF	Profound Medical Corporation
02/06/2023	14:40	GlobeNewswire Inc.	Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases	NASDAQ:PROF	Profound Medical Corporation